Abstract
Coronaviruses gained public attention during the severe acute respiratory syndrome (SARS) outbreak in East Asia in 2003 and spread of Middle Eastern respiratory syndrome (MERS) in 2012. Direct human-to-human contact and droplet are the main methods of transmission. Viral stability in aerosols on different surfaces supports evidence on indirect viral acquisition from fomites through the mucous membranes of the mouth, nose, and eyes. Given the pandemic circumstances, the level of evidence in COVID-19 and ophthalmology regarding eye infection, conjunctival transmission, and viral shedding through tears is insufficient. Presently, conjunctival transmission of coronaviruses has not been confirmed and remains controversial. Considering the physiology of the lacrimal system and ocular surface, the eyes are considered an immunoprotective site, with several antiviral molecules and anti-inflammatory proteins. Nevertheless, they represent an interface with the exterior world and face daily putative aggressors. Understanding the host’s ocular surface immunological and protective environment is crucial to clarify the potential of the conjunctiva as an entry route for SARS-CoV-2 and as part of this viral infection. We will discuss hypothetical ocular surface transmission mechanisms and related counterarguments addressed to both angiotensin-converting enzyme 2 receptors found on the conjunctival and corneal epithelia and lactoferrin, lysozyme, lipocalin and secretory IgA levels in the tear film. Hopefully, we will promote better understanding of this organ in COVID-19 infection and the potential transmission route that can be helpful in setting recommendations on best practices and protective guidelines to mitigate the disease spread.
Highlights
In December 2019, a new type of respiratory disease emerged in China, in Wuhan province, with several reports of new daily cases showing that the new disease was rapidly spreading
As severe acute respiratory syndrome (SARS)-CoV-2 requires angiotensin-converting enzyme 2 (ACE2) receptors to penetrate host cells, the presence of ocular renin-angiotensin system (RAS) raise the hypothesis of COVID-19 transmission through the ocular surface route
Regarding knowledge on pathophysiological mechanisms of SARS-CoV and Middle Eastern respiratory syndrome (MERS)-CoV pandemic, they use the same ACE2 receptors that SARS-CoV-2 uses, we could not find reports on clinical manifestations of ocular surface involvement during the SARS and MERS pandemic even though the presence of viral particles has been demonstrated by conjunctival polymerase chain reaction (PCR) during previous outbreaks in patients without conjunctivitis
Summary
In December 2019, a new type of respiratory disease emerged in China, in Wuhan province, with several reports of new daily cases showing that the new disease was rapidly spreading. The ocular surface, being exposed to aerosols and droplets, could be the route of transmission of the new coronavirus through direct penetration of the virus into the epithelial cells of the conjunctiva and cornea. As SARS-CoV-2 requires ACE2 receptors to penetrate host cells, the presence of ocular RAS raise the hypothesis of COVID-19 transmission through the ocular surface route. Collin et al (2021) found positivity with high expression in the superficial and basal conjunctival epithelium Both the cornea and conjunctiva with TMPRSS protease (Furin) expression show the favorable elements for the invasion by SARS-CoV-2, making this transmission route possible. To prove viable viruses with ocular transmission, the material collected from the first positive sample was inoculated into Vero E6 cells, and there was viral replication confirmed by PCR, suggesting the potential risk of infection through the eye. Regarding ophthalmologists’ exposure and their potential role as spreaders, Coroneo MT determined that a proximity of approximately 38 cm between ophthalmologists and patients during slit lamp exam would place them at risk for transmission given that viral particles could travel through aerosols expelled during breathing and speech at distances of 30 cm (Coroneo, 2021). Rokohl et al (2020) expressed their concern regarding the need for ophthalmologic offices to adopt protective measures, such as protective barriers in the slit lamp and mandatory disinfection of all ophthalmic equipment coming into direct contact with patients at the end of each medical appointment, to mitigate SARS-COV-2 spread
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.